NEW YORK – Euformatics said Thursday that it has engaged Brazilian life sciences product distributor Síntese Biotecnologia to help it expand into the Latin American market for next-generation sequencing informatics.
Síntese, of Belo Horizonte, Brazil, will have distribution rights to OmnomicsNGS, Euformatics' CE-marked variant interpretation and reporting software, as well as to OmnomicsQ, a quality control tool, the companies said.
"Working with Síntese as an agent to open doors for us in their well-established and broad customer base puts us in a great position to form new relationships and demonstrate the value of our tools to customers in the region," Tommi Kaasalainen, CEO of Espoo, Finland-based Euformatics, said in a statement.
"The Euformatics offering comes at the right time for the Brazilian market, as NGS takes off and more hospitals and laboratories are looking for the right solution to make their processes simpler," Síntese Business Director Henrique Vinagre added.
Euformatics moved into the Middle East, Asia, and Africa by virtue of a distribution agreement with Dubai-based Alliance Global in late 2019. The firm also has expressed a desire to expand into Southeast Asia.